Klotho Neurosciences, Inc. Files 8-K, Details Name Changes

Ticker: GRMLW · Form: 8-K · Filed: Apr 4, 2025 · CIK: 1907223

Sentiment: neutral

Topics: corporate-history, name-change

Related Tickers: KLTO

TL;DR

Klotho Neurosciences (KLTO) filed an 8-K confirming its name changes from ANEW Medical and Redwoods Acquisition.

AI Summary

Klotho Neurosciences, Inc. filed an 8-K on April 4, 2025, reporting an event on March 31, 2025. The filing indicates the company's former names were ANEW Medical, Inc. and Redwoods Acquisition Corp., with name changes occurring on June 24, 2024, and January 27, 2022, respectively. The company is incorporated in Delaware and its principal executive offices are located in Omaha, NE.

Why It Matters

This filing clarifies the corporate history and previous identities of Klotho Neurosciences, Inc., which is important for understanding its lineage and potential past activities.

Risk Assessment

Risk Level: low — The filing is primarily informational, detailing corporate history and name changes, with no immediate financial or operational risks disclosed.

Key Players & Entities

FAQ

What was the most recent name change for Klotho Neurosciences, Inc. and when did it occur?

The most recent name change was from ANEW Medical, Inc. to Klotho Neurosciences, Inc. on June 24, 2024.

What was the previous name of Klotho Neurosciences, Inc. before it was ANEW Medical, Inc.?

Before being ANEW Medical, Inc., the company was named Redwoods Acquisition Corp., with the name change occurring on January 27, 2022.

What is the filing date of this 8-K report?

This 8-K report was filed on April 4, 2025.

What is the earliest event date reported in this 8-K?

The earliest event date reported in this 8-K is March 31, 2025.

In which state is Klotho Neurosciences, Inc. incorporated?

Klotho Neurosciences, Inc. is incorporated in Delaware.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 4, 2025 regarding Klotho Neurosciences, Inc. (GRMLW).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing